74
Great Novel Therapeutics Biotech & Medicals
7427.TWO · TWO
$73.70 +0.68% (+$0.50)
1M +6.45%
Market Cap $3.80B
P/E Ratio -
Div. Yield -
ROE 15.89%
Piotroski F-Score Weak
2/9Valuation
3 /100
Expensive P/B 7.56x
P/S 3,155.71x
EV/EBITDA N/A
Growth
98 /100
Growing Book val. growth 11.71%
Rev. growth 30.68%
FCF growth N/A
Profitability
0 /100
Weak Net margin 8,089.05%
Op. margin 8,260.91%
FCF margin 7,313.53%
Quality
0 /100
Poor ROE 15.89%
ROA 18.50%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 24.12x
Int. coverage -1,026.23x
Debt/Equity 0.02x
Stability
26 /100
Unstable Rev. volatility 488.22%
EPS volatility 41.37%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 7427.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chia-Nan Chen
Employees
23
Headquarters
Taipei City